Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy

Table 5 Predictive performance of the radiomics signature and clinical model

Varibales and models	Sensitity	Specificity	Accuracy
Clinical model	0.27	0.95	0.71
T1WI	0.45	0.8	0.68
T1WI arterial phase	0.01	0.95	0.61
T1WI portal venous phase	0.64	0.85	0.77
T1WI delay phase	0.27	1	0.74
T2WI	0.55	0.9	0.77
ADC	0.54	0.85	0.76
DWI(b = 800)	0.72	0.45	0.55
Combined models	0.99	0.95	0.71

ISSN: 1471-230X